IRIS
metadata only
Organobodies: a robust and size-controllable system for generating scalable hiPSC-derived liver organoids for drug toxicity screening
Human hepatic organoids derived from pluripotent or adult stem cells offer powerful platforms for disease modeling and drug discovery. However, developing robust and scalable organoids capable of sustaining long-term functionality remains challenging. Here, we developed a novel, semi-defined approac
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Biobanked Liver Organoids: A Roadmap for Precision Hepatology.#323018
- Robust, long-term culture of endoderm-derived hepatic organoids for disease modeling#955732
- Integrating Human Intestinal Organoids into FDA's New Approach Methodologies for Drug Discovery.#1336
- Precision-cut liver slices as a model for evaluating therapeutic agents against hepatitis B and delta viruses#1099957
- Assessing the impact of data harmonization on human liver microsomal stability prediction model performance.#193421
Record · ID 1235967
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive